首页> 外文期刊>Cough >Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: effect of inhaled corticosteroids
【24h】

Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: effect of inhaled corticosteroids

机译:咳嗽变异性哮喘患者支气管反应性和咳嗽反射敏感性的变化:吸入糖皮质激素的影响

获取原文
           

摘要

Background Cough variant asthma (CVA) is a cause of chronic cough and a precursor of typical asthma. We retrospectively examined the longitudinal change in bronchial responsiveness and cough reflex sensitivity in CVA patients with respect to the effect of long-term inhaled corticosteroids (ICS). Methods Provocative concentration of methacholine causing a 20% fall in forced expiratory volume in one second (PC20-FEV1) and provocative concentration of capsaicin eliciting 5 or more coughs (C5) were measured before treatment and during a follow up period following relief of cough (median; 2.0 (range; 0.5 to 8.0) years after the initial visit) in a total of 20 patients with CVA (7 males and 13 females, mean ± SD age of 49.9 ± 12.9 years). Results Three of 8 patients not taking long-term ICS developed typical asthma compared to none of 12 patients taking ICS (p = 0.0171). PC20-FEV1 significantly (p < 0.0001) increased from 1.80 (GSEM, 1.35) to 10.7 (GSEM, 1.63) mg/ml in patients taking ICS but did not change in patients not taking ICS [2.10 (GSEM, 1.47) compared to 2.13 (GSEM, 1.52) mg/ml]. Cough threshold did not change in patients whether taking or not taking ICS. Conclusion Long-term ICS reduces bronchial hyperresponsiveness in CVA as recognized in typical asthma. Cough reflex sensitivity is not involved in the mechanism of cough in CVA.
机译:背景技术咳嗽变异性哮喘(CVA)是引起慢性咳嗽的原因,也是典型哮喘的前兆。我们回顾了长期吸入性糖皮质激素(ICS)的影响,CVA患者的支气管反应性和咳嗽反射敏感性的纵向变化。方法在治疗前和缓解咳嗽后的随访期间,测量引起乙酰呼出气量降低的乙酰甲胆碱浓度(PC20-FEV1),该浓度在一秒钟内(PC20-FEV1)和引起5次或更多咳嗽(C5)的辣椒素的刺激浓度。中位;初次就诊后2.0年(范围; 0.5至8.0)年)总计20例CVA患者(男7例,女13例,平均±SD年龄为49.9±12.9岁)。结果8例未长期服用ICS的患者中有3例患上典型的哮喘,而12例服用ICS的患者则无一例(p = 0.0171)。服用ICS的患者PC20-FEV1显着(p <0.0001)从1.80(GSEM,1.35)增加到10.7(GSEM,1.63)mg / ml,但未服用ICS的患者则没有变化[2.10(GSEM,1.47)与2.13 (GSEM,1.52)mg / ml]。无论是否服用ICS,患者的咳嗽阈值均未改变。结论长期ICS可减轻CVA中支气管高反应性,这在典型哮喘中已得到公认。咳嗽反射敏感性不参与CVA的咳嗽机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号